Related Experiment Video
Updated: May 22, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
An agnostic study of donor and component factors associated with transfusion-related changes in laboratory markers
Lucas D Ekström1, Mark Clements2, Nareg Roubinian3,4
1Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Background:
Donor and red blood cell (RBC) component factors may affect patient outcomes after RBC transfusions, but data on the magnitude and consequences of these associations are limited.
Study Design And Methods:
In this retrospective cohort study, we analyzed associations between 10 donor and component factors-including donor age, hemoglobin, parity, sex, and component storage time-and changes in 55 clinical laboratory markers measured within 24 h before and after RBC transfusions. Primary analyses used data from the Swedish SCANDAT3-S database, with findings replicated in the U.S. REDS-III database. The primary outcome was the transfusion-related change in pre- and post-transfusion values of the laboratory markers, normalized per RBC unit transfused.
Results:
After adjusting for the false discovery rate, 33 significant associations were identified, with 20 replicated in the SCANDAT replication sample or the REDS-III cohort after Bonferroni corrections, and 18 remaining after visual assessment. Higher donor hemoglobin concentration consistently led to greater increases in recipient hemoglobin and measures of RBC mass. Extended component storage times were associated with elevated recipient bilirubin and carboxyhemoglobin levels. Differences in recipient hemoglobin response between the SCANDAT3-S and REDS-III cohorts suggest potential variations in transfusion efficacy across populations and practices.
Discussion:
These findings suggest that considering donor hemoglobin and RBC component storage duration could enhance transfusion efficacy, providing avenues for personalized transfusion strategies to improve patient outcomes.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

